Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6821599 | Schizophrenia Research | 2018 | 7 Pages |
Abstract
Short-term (28-days) cannabis abstinence is not associated with improvement in psychotic symptoms, but may be associated with improvement in depressive symptomatology in patients with schizophrenia. Future studies employing larger samples as well as a continuous cannabis-using group may help to better characterize the causal effects of cannabis on symptom outcomes in this disorder.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Rachel A. Rabin, Karolina Kozak, Konstantine K. Zakzanis, Gary Remington, Tony P. George,